Department of Medicine, All India Institute of Medical Sciences, Delhi, India.
Drug Discov Ther. 2022 Jul 20;16(3):145-147. doi: 10.5582/ddt.2021.01012. Epub 2022 Jun 25.
Osmotic demyelination syndrome (ODS) and neuroleptic malignant syndrome (NMS) lead to severe neurological sequalae. Though currently thought to be different syndromes, literature suggests a relation between the two. We present the case of a 45-year-old male who was found to have chronic severe hyponatremia and underwent rapid correction of sodium and developed parkinsonism features. Magnetic resonance imaging (MRI) confirmed extrapontine myelinolysis (a type of ODS). The patient received haloperidol for agitated behavior and developed new features of rigidity, fever, tachycardia and elevated creatine phosphokinase (CPK) levels and thus neuroleptic malignant syndrome was suspected to overlap with ODS. We report this case highlighting the difficulty in differentiating the between ODS and NMS and their relationship.
渗透性脱髓鞘综合征 (ODS) 和神经阻滞剂恶性综合征 (NMS) 可导致严重的神经后遗症。虽然目前认为这是两种不同的综合征,但文献表明两者之间存在关联。我们报告了一例 45 岁男性的病例,该患者被发现患有慢性严重低钠血症,并进行了钠的快速纠正,随后出现帕金森病特征。磁共振成像 (MRI) 证实为脑桥外髓鞘溶解症 (一种 ODS 类型)。该患者因激越行为接受氟哌啶醇治疗,出现新的僵硬、发热、心动过速和肌酸磷酸激酶 (CPK) 水平升高的特征,因此怀疑重叠了 NMS 和 ODS。我们报告了这一病例,强调了区分 ODS 和 NMS 及其关系的困难。